Request Info / Demo
Back to all
Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

News
29/03/17

MyMeds&Me CEO Andrew Rut writes for the newly released Clinical & Contract Research Association (CCRA) yearbook, to analyse and discuss how artificial intelligence and machine learning might influence the future of pharmacovigilance study.

Read more in the CCRA Industry Yearbook 2017

MyMeds&Me and CCRA Yearbook - Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

You may also be interested in

Understanding of adverse events and good patient communication is essential to drive adherence
News

Understanding of adverse events and good patient communication is essential to drive adherence
Beyond the finish line - Dr Andrew Rut in PharmaTimes
News

Beyond the finish line - Dr Andrew Rut in PharmaTimes
Listen Now! Trust, verify, and disclose the expected and known side effects for the new coronavirus vaccines before the mass vaccination programs begin.
News

Listen Now! Trust, verify, and disclose the expected and known side effects for the new coronavirus vaccines before the mass vaccination programs begin.
Drug Safety During the COVID-19 Pandemic - Dr. Andrew Rut in Pharmaceutical Executive
News

Drug Safety During the COVID-19 Pandemic - Dr. Andrew Rut in Pharmaceutical Executive

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing info@mymedsandme.com.
  • ©2012–2024 MyMeds&Me. Registered in England & Wales under registration no. 07660726
  • 2 Crossways Business Centre, Bicester Road, Aylesbury, HP18 0RA
  • Freelance Web Designer

Cookies

We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.

DeclineAccept